Becoming a winning trader is one of the most difficult careers (90% of retail investors fail). I certainly st…
GLSI announced that the FDA approved the use of a commercially manufactured lot of GP2 vials in its Phase …
Kalshi is not sports betting. It’s not traditional gambling. And it’s not about being “right” more tha…
If you have not read the original GLSI analysis, this article builds directly on that foundation. You can …
Below is a clear, practical look at Greenwich LifeSciences, Inc. (NASDAQ: GLSI), covering its most recent …
If you like trading probabilities instead of guessing price direction, Kalshi is worth checking out. Kalshi l…
In the fast-paced world of finance, trading is becoming increasingly dynamic and complex. Despite having acc…
Options are generally unadvisable due to the large volume of losses retail traders experience. However, despi…